A good night's sleep might be an additional benefit some gain from taking weight-loss drugs like Ozempic and Zepbound, a new ...

WELT introduces a new treatment paradigm that unites drug + timing + patient‑specific real‑world data into a continuously adaptive therapeutic loop. The AI learns from each individual's patterns and ...

The Food and Drug Administration has approved Zepbound, a GLP-1 weight-loss drug from Eli Lilly & Co., for the treatment of moderate to severe sleep apnea certain patients with obesity. Photo courtesy ...

While resorting to taking melatonin or purchasing a new mattress remain options, natural sleep aids -- like GABA ...

Testing for a new sleep apnea drug has proven exceptionally successful. Not only has the drug allowed some patients to abandon their CPAP machines entirely, but it has also helped boost weight loss ...

An existing drug has shown it can significantly improve the quality of sleep for those suffering from obstructive sleep apnea (OSA), so much so that many trial participants were able to hang up their ...

A reduction in prescriptions of sleep drugs for older adults is associated with substantial health and economic benefits, according to an October study published in The Lancet Regional Health – ...

Intermezzo could help those who wake in the night, but some doctors cautious. April 4, 2012— -- Your eyes snap open, but the room is dark and the alarm clock reads 2 a.m. It's a frustrating but ...

A prospective study of 39 mother-infant dyads exposed to SARS-CoV-2 during pregnancy suggested that cognitive skills in ...

Commonly prescribed sleep medications such as zolpidem are not associated with a meaningful increase in the overall risk for ...

A new drug appears to reverse the fuzzy thinking caused by a lack of sleep. Studies in monkeys and people show that the drug restores the ability to perform complex mental tasks. The research is being ...

Among nearly 4.3 million pregnancies in a Medicaid database and a commercial insurance database, the adjusted pooled relative ...